Kidney
Newsletter
Keeping you up to date with the latest exciting advances and discussions in nephrology
Meet the editors
To contact a Vifor medical representative please email medinfo@viforpharma.com
SHPT
![](/sites/g/files/brlbcj1296/files/styles/editors/public/2022-08/Image%206.png?itok=P37-FZLE)
Global Medical Lead
Hyperphosphataemia
![](/sites/g/files/brlbcj1296/files/styles/editors/public/2021-12/editors-img2.png?itok=m_uTxjRT)
Global Medical Affairs Director
![](/sites/g/files/brlbcj1296/files/styles/editors/public/2022-08/Image%209.png?itok=o8J_Rjcy)
Senior Global Medical
Affairs Director
![](/sites/g/files/brlbcj1296/files/styles/editors/public/2021-12/editors-img4.png?itok=MEnGCe7D)
Global Medical Lead
![](/sites/g/files/brlbcj1296/files/styles/editors/public/2022-08/Image%205.png?itok=MroZWc-u)
Senior Medical Liaison
Netherlands
FOOTNOTES
AAV, anti-neutrophil cytoplasmic auto-antibody-associated vasculitis; CKD-aP, chronic kidney disease-associated pruritus; CKD-MBD, chronic kidney disease-mineral bone disorder; HK, hyperkalaemia.